April 24, 2018
Research led at the Yale School of Public Health have found that the majority of published papers analyzing the cost-effectiveness of a widely used test for breast cancer used a study design that can increase bias. Oncotype DX, a gene-expression profiling test, is used in clinical care to guide chemotherapy […]